0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editorial | 
David D. Waters, MD; Priscilla Y. Hsue, MD; Sripal Bangalore, MD, MHA
JAMA. 2016;315(15):1571-1572. doi:10.1001/jama.2016.3670.

Original Investigation | 
Steven E. Nissen, MD; Erik Stroes, MD, PhD; Ricardo E. Dent-Acosta, MD; et al.
JAMA. 2016;315(15):1580-1590. doi:10.1001/jama.2016.3608.
Includes: CME, Supplemental Content

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18375.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(3):243. doi:10.1001/jama.2015.18729.

JAMA Clinical Challenge | 
Elizabeth K. Jones, MD; Nina Mingioni, MD; Jason B. Lee, MD
JAMA. 2015;314(16):1740-1741. doi:10.1001/jama.2015.9391.

From the JAMA Network | 
Mark Olfson, MD, MPH
JAMA. 2015;313(12):1256-1257. doi:10.1001/jama.2014.15743.

The Art of JAMA | 
Carrie A. Butt
JAMA. 2014;312(17):1722-1723. doi:10.1001/jama.2013.279811.

The Art of JAMA | 
Jeanette M. Smith, MD
JAMA. 2014;312(12):1180-1181. doi:10.1001/jama.2013.279741.

Original Investigation |  FREE
Massimo Imazio, MD; Antonio Brucato, MD; Paolo Ferrazzi, MD; et al.
JAMA. 2014;312(10):1016-1023. doi:10.1001/jama.2014.11026.
Includes: Supplemental Content

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;312(9):955-957. doi:10.1001/jama.2014.10644.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Brief Report  | 
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib A Phase 2 Clinical Trial
Mark A. Dickson, MD; Gary K. Schwartz, MD; Mary Louise Keohan, MD; et al.
JAMA Oncology
Research Letter  | 
Comparison of Neurocognitive Function After Anthracycline-Based Chemotherapy vs Nonanthracycline-Based Chemotherapy
Kathleen Van Dyk, PhD; Laura Petersen, MS; Patricia A. Ganz, MD
JAMA Oncology
Original Investigation  | 
Cardiovascular Disease After Aromatase Inhibitor Use
Reina Haque, PhD; Jiaxiao Shi, PhD; Joanne E. Schottinger, MD; et al.
JAMA Dermatology
Original Investigation  | 
Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma A Systematic Review and Pooled Analysis of Interventional Studies
Audrey A. Jacobsen, BA; Adam S. Aldahan, BS; Olivia B. Hughes, BS; et al.